Search Results

You are looking at 101 - 110 of 668 items for :

  • Refine by Access: All x
Clear All
Full access

Stephen B. Edge and David G. Sheldon

node dissection for intraductal breast carcinoma—Is it indicated? Cancer 1987 ; 59 : 1819 – 1824 . 9 Schwartz GF Feig SA Patchefsky AS . Significance and staging of nonpalpable carcinomas of the breast . Surg Gynecol Obstet 1988 ; 166

Full access

Margaret von Mehren, R. Lor Randall, Robert S. Benjamin, Sarah Boles, Marilyn M. Bui, Kristen N. Ganjoo, Suzanne George, Ricardo J. Gonzalez, Martin J. Heslin, John M. Kane III, Vicki Keedy, Edward Kim, Henry Koon, Joel Mayerson, Martin McCarter, Sean V. McGarry, Christian Meyer, Zachary S. Morris, Richard J. O'Donnell, Alberto S. Pappo, I. Benjamin Paz, Ivy A. Petersen, John D. Pfeifer, Richard F. Riedel, Bernice Ruo, Scott Schuetze, William D. Tap, Jeffrey D. Wayne, Mary Anne Bergman, and Jillian L. Scavone

selected circumstances. Given the risk for hematogenous spread from a high-grade sarcoma to the lungs, imaging of the chest (CT without contrast [preferred] or radiograph) is essential for accurate staging. Abdominal/pelvic CT should be considered for

Full access

Jonathan S. Zager, Jane L. Messina, L. Frank Glass, and Vernon K. Sondak

. 30. Lemos BD Storer BE Iyer JG . Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system . J Am Acad Dermatol 2010 ; 63 : 751 – 761

Full access

Nathan Y. Yu, Terence T. Sio, Vinicius Ernani, Panayiotis Savvides, and Steven E. Schild

Utilization of MRI for CNS staging varied by cancer facility in the pooled NCCTG analysis and the National Cancer Database analysis. 14 , 16 In the context of the Japanese randomized trial, the lack of MRI for CNS is a significant limitation when interpreting

Full access

Jenna F. Borkenhagen, Daniel Eastwood, Deepak Kilari, William A. See, Jonathan D. Van Wickle, Colleen A. Lawton, and William A. Hall

subsequently revised in 1975 by Dr. Hugh Jewett. 3 The Whitmore-Jewett system was succeeded by the TNM staging system for prostate cancer, first formulated in 1987 and implemented by the AJCC in the United States in 1992. 4 , 5 Pathologic T2 (pT2

Full access

Emily Chan, Paul E. Wise, and A. Bapsi Chakravarthy

middle third has peritoneum only on a portion of its anterior aspect. The lower third of the rectum has no peritoneal covering. The 7th edition of the AJCC Cancer Staging Manual takes this into consideration and defines different T stages based on tumor

Full access

Ali A. Mokdad, Amit G. Singal, Jorge A. Marrero, Hao Zhu, and Adam C. Yopp

for HCC remains below 20% in the United States. 2 Poor HCC outcomes are largely attributed to low rates of HCC surveillance and high rates of late stage diagnosis. 3 , 4 Accurate HCC staging is important for patient prognostication, treatment

Full access

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Ajjai Alva, Michael Baine, Kathryn Beckermann, Maria I. Carlo, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Arpita Desai, Yasser Ged, Saby George, John L. Gore, Naomi Haas, Steven L. Hancock, Payal Kapur, Christos Kyriakopoulos, Elaine T. Lam, Primo N. Lara, Clayton Lau, Bryan Lewis, David C. Madoff, Brandon Manley, M. Dror Michaelson, Amir Mortazavi, Lakshminarayanan Nandagopal, Elizabeth R. Plimack, Lee Ponsky, Sundhar Ramalingam, Brian Shuch, Zachary L. Smith, Jeffrey Sosman, Mary A. Dwyer, Lisa A. Gurski, and Angela Motter

, 2019. Available at: http://seer.cancer.gov/statfacts/html/kidrp.html . 3. Moch H , Gasser T , Amin MB , Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma

Full access

Aaron T. Gerds, Jason Gotlib, Prithviraj Bose, Michael W. Deininger, Andrew Dunbar, Amro Elshoury, Tracy I. George, Ivana Gojo, Krishna Gundabolu, Elizabeth Hexner, Gabriela Hobbs, Tania Jain, Catriona Jamieson, Andrew T. Kuykendall, Brandon McMahon, Sanjay R. Mohan, Vivian Oehler, Stephen Oh, Animesh Pardanani, Nikolai Podoltsev, Erik Ranheim, Lindsay Rein, Rachel Salit, David S. Snyder, Brady L. Stein, Moshe Talpaz, Swapna Thota, Pankit Vachhani, Martha Wadleigh, Katherine Walsh, Dawn C. Ward, Mary Anne Bergman, and Hema Sundar

-Eo requires a multidisciplinary team approach, preferably in specialized medical centers. The NCCN Guidelines for Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes include recommendations for the diagnosis, staging, and treatment of any of the

Full access

Casey L. O’Connell and Howard A. Liebman

, demographics, and outcome of cancer-related VTE is generally based on reported symptomatic events. However, the unsuspected finding of PE, DVT, or intra-abdominal thrombosis in the splanchnic or visceral veins is not uncommon on routine staging CT scans of